$PMHS

Polomar Health Services, Inc. (PMHS): Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Polomar Health Services, Inc. (PMHS) filed an SEC Form 8-K — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers. EX-3.1 2 ex3-1.htm EX-3.1 Exhibit 3.1 AMENDED AND RESTATED BYLAWS OF POLOMAR HEALTH SERVICES, INC., a Nevada corporation (Effective as of July 1, 2026) These Amended and Restated Bylaws (these “Bylaws”) of Polomar Health Services, Inc., a Nevada corporation (the “Corporation”), a

Original reporting
Published Jul 6, 2026, 8:38 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jul 6, 2026, 8:40 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefCorporate actions
Primary signal
$PMHS
Neutral
low confidence
Mentioned
$PMHS
Relevance
6/10
alphai data visualization · based on SEC EDGAR 8-K
Decision brief

The 30-second read

$PMHSNeutralLow
01

Why it matters

Based on the provided excerpt, the actionable content is governance documentation; without the specific executive/director changes and compensation terms, the trading signal is weak.

02

Market read

This is a governance/compensation update with no disclosed financial metrics in the provided text, so it is unlikely to drive a major repricing absent material executive details in the full exhibits.

03

What to watch

Traders should verify the full 8-K exhibits for named officer departures/elections and any quantified compensation/benefit changes; those details—not the bylaws boilerplate—would determine materiality.

Relevance 6/10Novelty 3/10Timing: Filed July 6, 2026 (after market close) via SEC 8-K Item 5.02.

Background

The filing is an SEC Form 8-K under Item 5.02 covering director/officer changes and compensatory arrangements, and it includes amended and restated bylaws effective July 1, 2026.

Company-level read

Ticker impact

$PMHSNeutralLow confidence
Context

Polomar Health Services filed an 8-K for director/officer departures and elections plus officer compensatory arrangements under Item 5.02.

Expected impact

Likely limited immediate impact unless the omitted exhibits specify material executive changes or compensation terms; otherwise treat as low-volatility governance noise.

Evidence & confidence

The excerpt shows amended bylaws effective July 1, 2026 and references Item 5.02, but does not include the specific names, departures, elections, or compensation figures that would drive a stronger trading reaction.

Market effects

Minimal—this is company-specific governance/compensation documentation with no sector-wide regulatory or operational change disclosed.

None indicated.

None indicated.

Counterpoint

If the missing portions of Item 5.02 include a CEO/CFO departure or materially different compensation tied to performance, the market reaction could be larger than the bylaws-only excerpt suggests.

Key entities

  • Polomar Health Services, Inc.

    Subject of the SEC 8-K; governance/officer changes and compensatory arrangements under Item 5.02.

Related articles

$AVGOHighAI 9/10

Broadcom (AVGO) Nears $70B Debt Financing Deal, Sources Say

Broadcom (AVGO) is in talks to raise $70B-$80B in debt for AI chip financing, with Blackstone and Apollo involved. The deal supports AI companies like Anthropic and extends a June partnership. Shares rose 1% on the news. The financing structure keeps debt off Broadcom's balance sheet, but the company guarantees part of it. The deal's size and terms remain fluid, with potential execution risks.

$BAHighAI 9/10

Air Force awards Boeing $131 billion ceiling contract for F-15 production, modernization

The U.S. Air Force awarded Boeing a $131.23 billion contract for F-15 production, modernization, and sustainment through 2037. The contract includes options for foreign military sales to several countries. Initial funding is $343,740 for fiscal 2026. Boeing will perform the work in St. Louis. The contract does not guarantee full spending and includes no immediate jet orders.

$AECMed

SW US: Anfield wants $50M for Utah mill

Anfield Energy (TSXV, Nasdaq: AEC) plans to raise $50M to refurbish Utah's Shootaring Canyon mill, aiming for a 2028 reopening. The mill will process uranium and vanadium, reducing U.S. reliance on imports. Capital expenditures are estimated at $80.1M, with flexibility in financing options. The company expects a mill licence by late 2024 or early 2027, unlocking financing and construction. An updated PEA forecasts significant after-tax NPV and IRR, with production from Velvet-Wood and Slick Rock